Oprah Winfrey shares her transformative weight-loss journey with GLP-1 medications, challenging societal perceptions of willpower and obesity in a candid podcast conversation with Dr. Ania Jastreboff.

A Medscape survey found that a strong majority of physicians believe high-risk patients should have easier access to new weight loss drugs.

Ro details dietary choices that may help Wegovy's capacity to regulate appetite and foster a healthier weight as well as potentially alleviate some of the drug's common side effects.

Colorado plans to limit insurance coverage for weight-loss drugs like Wegovy and Ozempic for thousands of state employees.

American doctors have now discovered the injections put users at 'significantly higher' risk compared to three other common diabetes drugs.

Socially responsible companies are businesses that integrate social and environmental considerations into their core operations and decision-making processes.

The diabetes startup is prescribing GLP-1 drugs for weight loss to help employers manage costs. Its CEO says it's nearing ...

A major new study has revealed a long list of benefits and some little-known risks of Ozempic and other GLP-1 medications.

GLP-1 medications linked to a lower risk of dementia and addiction but higher risk of kidney, pancreatic, and ...

The media queen also confessed that she was reluctant to take a GLP-1 drug because she felt it was “the easy way out.” That ...

Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to treat ...

Concern is growing among Democrats after President Donald Trump reversed some of the former president’s executive orders, ...